ATRX and type 2 diabetes mellitus: Collectively, these results show that the RAD54 mutations do not affect the intrinsic RAD54 ATPase, while the phosphomimic mutations (T2D and T3D) compromise the stimulation effect of RAD51 and thus decrease the ATPase activity of the RAD51-RAD54 complex under more physiological ionic strength conditions.